Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Pharma, Bio-Pharma...

    Pharma, Bio-Pharma manufacturing units to follow Apprentices Act: CDSCO issues advisory

    Farhat NasimWritten by Farhat Nasim Published On 2019-09-08T16:34:52+05:30  |  Updated On 13 Aug 2021 3:51 PM IST

    New Delhi: Through a recent advisory, the apex drug regulatory body- Central Drugs Standard Control Organization (CDSCO) has directed all pharmaceutical Industry associations to ask their members having the Pharmaceuticals and Bio-Pharmaceutical manufacturing units to follow the Apprentices Act, 1961.


    Under Section 8 of the Apprentices Act, 1961, there are provisions for number of apprentices for a designated trade and optional trade wherein it is mentioned that the Central Government shall prescribe the number of apprentices to be engaged by the employer for designated trade and optional trade and several employers may join together either themselves or through an agency, approved by the Apprenticeship Adviser, according to the guidelines issued from time to time by the Central Government in this behalf, for the purpose of providing apprenticeship training to the apprentices under them.


    Rule 7A of the Apprenticeship Rules, 1992 provides the provisions for regulation of optional trade (other than designated trade under the Apprentices Act 1961) and Rule 7B of the said rules provides the provisions for number of apprentices for designated and optional trade wherein it is mentioned that each establishment shall engage apprentices in a band of 2.5 per cent to 10 per cent total strength of the establishment including contractual staffs.


    National Apprenticeship Promotion Scheme (NAPS) is a new scheme of Government of India launched on 19th August 2016 to promote apprenticeship. The main objective of the scheme is to promote apprenticeship training and to increase the engagement of apprentices. Apprenticeship Training consists of Basic Training and On-the-Job Training or Practical Training at work-place in the industry.


    The candidates can be first trained on the requirements to gain awareness on the nature of the job role and then on the shop floor. This programme is bound to enhance the probability of employment as the candidate will acquire the skill set required for e job role during the apprenticeship period by gaining valuable practical experience. Under NAPS, the industry can get various benefits including funds for basic training to candidates and monthly reimbursement of a portion of the stipend.


    CEO of Life Sciences Sector Skill Development Council (LSSSDC) who is designated as Joint Apprenticeship Advisor by the Government of India, requested to issue advisory for implementing the Apprentice Act, 1961 in the Life Science Sector for exposing the qualified manpower in India who are ready to be employed.

    advisoryApprentice Actapprentice job in pharma sectorApprenticeship TrainingbiopharmaCDSCOCentral Drugs Standard Control OrganizationCentral Governmentjoint apprenticeshipLife Science Sectorlife sciencesLSSSDCon job trainingpharmapharma newspharma news indiaPractical TrainingSection8 Apprentices ActSkill Development Council

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok